Vaccine for 2-3 year olds may get approval by February: Adar Poonawalla
New Delhi, 21/10:Adar Poonawalla, CEO of Pune-based Serum Institute of India, said on Thursday that his company has spent Rs 10,000 crore for the production and distribution of the Kovishield vaccine. Poonawalla also said that handling public scrutiny and accountability was one of the biggest challenges for him. Poonawalla also said that his company is…
